Work

Supplementary Figures S1-S4 from ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer

Year: 2025

Type: supplementary-materials

Abstract: Supplementary Figure 1. ACTA2 expression was elevated in the molecular subtype with the worst prognosis (Group 4). Supplementary Figure 2. ACTA2 expression stratified by microsatellite stability status in the pooled cohort. Supplementary Figure 3. Alternatively tested thresholds to stratify patients into ACTA2-High and ACTA2-Low groups.Supplementary Figure 4. ACTA2 expression stratified by microsatellite stability status in the immune checkpoint inhibitor cohort.

DOI: 10.1158/1078-0432.30706891

Authors: Sunho Park, John D. Karalis, Changjin Hong, Jean R. Clemenceau, Matthew R. Porembka, In-Ho Kim, Sung Hak Lee, Sam C. Wang, Jae-Ho Cheong, Tae Hyun Hwang

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4416628843

Cites:

Cited by:

Related to: 10